266 filings
Page 2 of 14
8-K
af7w7gi2o00 eo87x0x7
15 Aug 22
Results of Operations and Financial Condition
6:14pm
8-K
odmsl8g6aryiwkl8n6l
29 Jun 22
Results of Operations and Financial Condition
5:03pm
8-K
1voxihz7e0
29 Jun 22
Regulation FD Disclosure
9:00am
8-K
583d xppz26
11 May 22
Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer
5:13pm
8-K
8b4eb3e28kbtoe6
18 Apr 22
Departure of Directors or Certain Officers
4:35pm
8-K
7txjtrzy3lu
4 Apr 22
Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline
11:26am
8-K
c2x7 zc9y924p
15 Feb 22
Results of Operations and Financial Condition
12:00am
8-K
ma6fhx
9 Dec 21
Entry into a Material Definitive Agreement
10:47am
8-K
nf2gtrjt2q6zaoewn6w
2 Dec 21
Entry into a Material Definitive Agreement
6:10am
8-K
6xp 49eqhh1obzcr9c0
2 Dec 21
Entry into a Material Definitive Agreement
6:07am
8-K
f1hztpke gop
15 Nov 21
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2022
12:00am
8-K
un8vovhb5 qu
16 Aug 21
Results of Operations and Financial Condition
5:28pm
8-K
t2b22la1 w4
14 Jun 21
Results of Operations and Financial Condition
5:15pm
8-K
v1ud3 foxx
5 May 21
Other Events
9:56am
8-K
j5dca8v5vq9wy
29 Apr 21
Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer
4:01pm
8-K
swzokwfwm1
12 Apr 21
Departure of Directors or Certain Officers
6:15am
8-K
5fuanblzq4bv9z5
16 Feb 21
Results of Operations and Financial Condition
12:00am
8-K
1h2t3 zwg
16 Nov 20
Results of Operations and Financial Condition
4:39pm
8-K
vfoqqve8xrajoh hs
27 Aug 20
Unregistered Sales of Equity Securities
12:00am
8-K
8oafb7wvge53xw95
17 Aug 20
Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2021
6:09am